Cedar Brook Financial Partners’s CVS Health CVS Stock Holding History

Cedar Brook Financial Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,461	Closed	-$356K	–	97
2024 Q1	$356K	Sell	4,461 -146	-3%	-$11.2K	0.07%	280
2023 Q4	$364K	Buy	4,607 +1,452	+46%	+$103K	0.08%	245
2023 Q3	$220K	Sell	3,155 -1,029	-25%	-$72.9K	0.06%	327
2023 Q2	$289K	Sell	4,184 -38	-0.9%	-$2.7K	0.07%	289
2023 Q1	$314K	Sell	4,222 -35	-0.8%	-$2.94K	0.08%	262
2022 Q4	$397K	Buy	4,257 +154	+4%	+$14.9K	0.11%	204
2022 Q3	$391K	Buy	4,103 +405	+11%	+$40.1K	0.13%	195
2022 Q2	$343K	Sell	3,698 -159	-4%	-$15.5K	0.11%	216
2022 Q1	$390K	Buy	3,857 +216	+6%	+$22.7K	0.1%	219
2021 Q4	$376K	Buy	+3,641	New	+$336K	0.1%	227
2021 Q3	–	Sell	-2,903	Closed	-$242K	–	357
2021 Q2	$242K	Buy	+2,903	New	+$238K	0.07%	314

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cedar Brook Financial Partners's CVS Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,461 shares — an estimated $356K sold.

Cedar Brook Financial Partners first reported a position in CVS in Q2 2021 and held it in 11 quarters. The position peaked at $397K in Q4 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Cedar Brook Financial Partners reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Cedar Brook Financial Partners sold 4,461 CVS Health shares in Q2 2024, an estimated $356K.
Cedar Brook Financial Partners first reported a position in CVS Health in Q2 2021 and held it in 11 quarters.
Cedar Brook Financial Partners's CVS Health position peaked at $397K in Q4 2022.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.